BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2009
View Archived Issues
Trastuzumab treatment for breast cancer associated with cardiotoxicity
Read More
Clopidogrel triple therapy effective in AMI in diabetics; novel approach to clopidogrel described
Read More
Takeda claims novel tyrosine kinase inhibitors
Read More
Novel annelated pyridazines claimed by Amgen for cancer treatment
Read More
Jenrin Discovery claims novel cannabinoid receptor antagonists
Read More
Novel compounds for the treatment of hepatitis C claimed by Abbott
Read More
Novel beta2-adrenoceptor agonists described by Sepracor for the treatment of bronchoconstriction
Read More
Improvement of Raynaud's phenomenon seen with topical nitroglycerin formulation MQX-503
Read More
GENZ-112638 shows safety and efficacy in phase II trial for Gaucher's disease
Read More
Daiichi completes patient enrollment in phase III clinical trial of influenza drug CS-8958
Read More
Diamyd to combine U.S. and European phase III trials of diabetes vaccine Diamyd
Read More
Flecainide shows promise in catecholaminergic polymorphic ventricular tachycardia therapy
Read More
NexBio forms clinical advisory board for influenza drug Fludase
Read More
FDA accepts for review Vion's NDA for Onrigin in AML
Read More
DSMB recommends continuation of phase IIb study of Rockwell's SFP in ESRD
Read More
Can-Fite commences phase I/II CF-102 trial in liver cancer
Read More
Cangene obtains rights to commercialize certain biotech drugs from Apotex
Read More
Clavis initiates phase II intravenous CP-4126 trial in advanced pancreatic cancer
Read More
GlaxoSmithKline and Pfizer enter agreement to create a new HIV company
Read More
GlobeImmune initiates phase I Tarmogen trial in CEA-overexpressing cancers
Read More
Stanford study of malaria vaccine requires more participants
Read More
Viral Genetics pursues promising new Lyme disease therapy with new grant
Read More
Copaxone approved by Health Canada for isolated syndrome suggestive of MS
Read More
Virionyx changes name to Innate Therapeutics
Read More